Brian W. Brannigan
- Oncology top 0.1%
- Cancer Cells and Metastasis 8
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 2
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 6
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 10
- Molecular Biology top 0.5%
- Renal and related cancers 2
- PI3K/AKT/mTOR signaling in cancer 2
- Genetics top 2%
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Daniel A. HaberDaphne W. BellThomas J. LynchRoss A. OkimotoRaffaella SordellaPatricia L. HarrisJeff SettlemanSara M. Haserlat
- Partner nations
- United StatesItalyCanada
In The Last Decade
Brian W. Brannigan
25 papers receiving 15.0k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 9.5k
- Cancer Research 4.3k
- Pulmonary and Respiratory Medicine 9.1k
- Molecular Biology 6.0k
- Genetics 509
Countries citing papers authored by Brian W. Brannigan
This map shows the geographic impact of Brian W. Brannigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian W. Brannigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian W. Brannigan more than expected).
Fields of papers citing papers by Brian W. Brannigan
This network shows the impact of papers produced by Brian W. Brannigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian W. Brannigan. The network helps show where Brian W. Brannigan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian W. Brannigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 15 | |
| 2 | Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasisbreakdown → | 2014 | 1786 |
| 3 | 2014 | 1 | |
| 4 | 2014 | 79 | |
| 5 | 2014 | 2 | |
| 6 | 2012 | 217 | |
| 7 | 2010 | 42 | |
| 8 | 2009 | 83 | |
| 9 | 2009 | 12 | |
| 10 | Detection of Mutations in EGFR in Circulating Lung-Cancer Cellsbreakdown → | 2008 | 1295 |
| 11 | 2008 | 10 | |
| 12 | 2008 | 64 | |
| 13 | 2007 | 225 | |
| 14 | 2006 | 133 | |
| 15 | Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinibbreakdown → | 2005 | 774 |
| 16 | 2005 | 380 | |
| 17 | 2005 | 104 | |
| 18 | Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trialsbreakdown → | 2005 | 518 |
| 19 | Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinibbreakdown → | 2004 | 8906 |
| 20 | 1992 | 22 |
About Brian W. Brannigan
Brian W. Brannigan is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 15.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Cells and Metastasis (8 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Genomics and Diagnostics (6 papers), Renal and related cancers (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Microtubule and mitosis dynamics (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (9.5k citations), Cancer Research (4.3k citations) and Pulmonary and Respiratory Medicine (9.1k citations). Brian W. Brannigan has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Daniel A. Haber, Daphne W. Bell, Thomas J. Lynch, Ross A. Okimoto, Raffaella Sordella, Patricia L. Harris, Jeff Settleman, Sara M. Haserlat, Frank G. Haluska and Jeffrey G. Supko. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.